Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | DHODH | Q02127 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12086229 | 0.95 | CYP1A2 (0.32) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL2724992 | 0.95 | CYP1A2 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL12086133 | 0.91 | CYP1A2 (0.32) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL2711496 | 0.91 | MEN1 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL2727504 | 0.91 | CYP1A2 (0.36) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL12086211 | 0.90 | CYP1A2 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL20113933 | 0.88 | MEN1 (0.33) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL2727120 | 0.88 | CYP1A2 (0.32) | CYP1A2CYP3A4CYP2C9CYP2C19CYP2D6 | |
| SCHEMBL2725445 | 0.88 | TRPA1 (0.32) | CYP1A2HSD17B1HSD17B2TRPA1 | |
| SCHEMBL2726840 | 0.86 | TRPA1 (0.33) | HSD17B1HSD17B2TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| EP-2445987-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | Cyalume Technologies, Inc (US) | 2012-05-02 | — | — | EP | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| WO-2010151654-A1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECHNOLOGIES, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | CYP1A2 22/4885CYP3A4 18/4885CYP2C9 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.